Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
14 July 2015 08:47
Breast cancer patients could benefit from having progesterone added to their treatment, data suggests
Breast cancer outlooks could be improved by having a widely available female hormone added to treatments, research suggests.
Progesterone, which is involved in signals between cell molecules, has been found to hold back tumour growth.
Cancer Research UK predicts adding the hormone to treatments could benefit half of breast cancer patients.
Breakthrough
The fact that breast cancer patients whose tumours have progesterone receptors - molecules sensitive to the hormone - often have a better outlook has puzzled scientists for a number of decades.
But experts at the Cancer Research UK Cambridge Institute believe they have finally come up with the answer.
They used cutting-edge technology to identify the crucial role that progesterone receptors play in breast cancer.
The progesterone receptor was found to "talk to" another receptor sensitive to the hormone oestrogen, which fuels breast cancer in a large number of cases.
This applies a brake on the oestrogen receptor's ability to stimulate tumours.
Travel plans
Around 50,000 new cases of breast cancer are diagnosed each year in the UK.
But a diagnosis does not mean life has to stop.
Breast cancer travel insurance gives patients the peace of mind they need to explore the world.
Clinical trial
The researchers claim half of the 50,000 new patients could potentially benefit from their discovery.
Dr Jason Carroll, one of the authors of the study, says the finding provides a strong case for a clinical trial to investigate the potential benefit of adding progesterone to drugs that target the oestrogen receptor.
He claims doing so could improve treatment for the majority of hormone-driven breast cancers.
Drugs such as Tamoxifen are commonly used to treat oestrogen-sensitive breast cancers. They block the hormone's receptor.
In future, they could be combined with progesterone to mount a two-pronged attack on the disease.
The findings of the new study were reported in the Nature journal.
18 October 2018
The UK's average life expectancy is predicted to increase from 80.8 years to 83.3 years over the next 20 years, according to new research.
[more...]
17 October 2018
Family doctors are being urged to prescribe physical activity for patients living with some of the most common medical conditions.
16 October 2018
Patients with brain tumours lose out on almost £15,000 per year, a new report has revealed.
13 October 2018
Chris Grayling has given his "categorial assurance" to Parliament that a no-deal Brexit will not ground flights in and out of the UK, despite recent warnings from experts that this remains a possibility.
12 October 2018
The rising cost of fuel could force more airlines out of business, the boss of easyJet has warned.
11 October 2018
The image of the boozy backpacker might be a thing of the past as a new study suggests more and more youngsters are shunning alcohol completely.
10 October 2018
The NHS says just one in 10 drinks sold in English hospitals will be sugar-sweetened, as part of its bid to curb rising obesity levels.
09 October 2018
More than 260,000 diabetes patients were put at risk of lasting harm or even death during hospital stays last year due to medication errors, a new report has revealed.
06 October 2018
NHS patients with a specific type of lymphoma will soon be able to access a "game-changing" new treatment, health officials have revealed.
05 October 2018
People living with diabetes are being warned they might be "unwittingly" storing their insulin incorrectly.
04 October 2018
The world's first commercial jet part-powered by a new form of biofuel touches down in London on Wednesday (3rd October).
03 October 2018
New 'hotel-style' carriages that were due to be rolled out for the Caledonian Sleeper have been delayed until next year.